Background

Modern health challenges - including cognitive decline, cardiovascular and metabolic disorders, hepatic dysfunction, chronic inflammation, and reproductive difficulties - are increasingly linked to deficiencies in omega-3 fatty acids, phospholipids, and choline.

Conventional fish oil, typically in triglyceride or ethyl ester form, suffers from poor bioavailability, gastrointestinal tolerance issues, and limited brain targeting.

Phospholipid-bound omega-3s derived from Antarctic krill oil, together with the unique long-chain fatty acid docosapentaenoic acid (DPA), represent a next-generation nutritional strategy.

By delivering EPA, DHA, and DPA in phosphatidylcholine-bound form and naturally coexisting with astaxanthin, these lipids achieve superior absorption, membrane compatibility, oxidative stability, and direct functional targeting.

---

Objective

This project, conducted within the Keyora Phospholipid–Omega Framework, aims to investigate the integrative physiological benefits of phospholipid-bound omega-3 fatty acids and DPA across multiple organ systems.

The specific objective of the Keyora framework is to elucidate their mechanisms in neurocognitive protection, cardiovascular and hepatic regulation, inflammation resolution, reproductive health, and systemic resilience, with emphasis on their bioavailability advantages and synergistic actions.

---

Mechanistic Pathways

1. Neurocognitive Support

• DHA-PC crosses the blood–brain barrier and incorporates directly into neuronal membranes, sustaining synaptic plasticity, neurotransmission, and memory formation.
• DPA enhances cerebral microcirculation via angiogenesis and endothelial progenitor cell mobilization, while producing unique pro-resolving mediators that counteract neuroinflammation.
• Astaxanthin penetrates mitochondria, protecting neurons from oxidative stress and fatigue.

2. Cardiovascular and Metabolic Regulation

• EPA/DHA-PC improve lipid metabolism by reducing triglycerides, raising HDL, and suppressing LDL oxidation.
• DPA exerts antithrombotic effects through platelet membrane integration, inhibits aggregation, and promotes vascular repair via VEGF upregulation.
• Phosphatidylcholine facilitates reverse cholesterol transport and stabilizes vascular endothelium.

3. Hepatic Function and Lipid Homeostasis

• Phosphatidylcholine (PC) is essential for VLDL assembly and triglyceride export, preventing lipid accumulation in hepatocytes.
• Supplementation improves bile acid fluidity, reduces gallstone risk, and maintains hepatic membrane integrity.
• Combined omega-3s and PC help alleviate NAFLD/MASLD and insulin resistance.

4. Inflammation and Oxidative Stress Resolution

• EPA/DHA-derived resolvins and DPA-derived protectins accelerate the resolution phase of inflammation, reducing NF-κB, IL-6, and TNF-α signaling.
• Astaxanthin provides mitochondrial antioxidant defense, synergistically stabilizing EPA/DHA activity and reducing oxidative tissue damage.

5. Reproductive and Systemic Health

• Male fertility: DPA and DHA improve sperm membrane fluidity, motility, and mitochondrial stability.
• Female health: PC supports estrogen metabolism and endometrial receptivity; DHA and choline aid fetal neurodevelopment.
• Systemic resilience: Omega-3 phospholipids and astaxanthin support joint recovery, ocular health, and immune stability under high stress.

---

Synergistic Framework

The combined matrix of phospholipid-bound omega-3s (EPA, DHA, DPA), phosphatidylcholine, and astaxanthin creates a multi-layered synergy:

Structural integration:

Phospholipid-bound forms directly embed into cell membranes.

Biofunctional signaling:

EPA, DHA, and DPA modulate lipid mediators for vascular, neural, and inflammatory control.

Nutritional gap coverage:

Addresses deficiencies in omega-3s, choline, and antioxidant defense prevalent in modern diets.

This framework ensures coordinated benefits across brain, liver, vasculature, immune system, and reproductive health.

---

Clinical & Preclinical Evidence

1. Clinical trials confirm 1.3–3× higher absorption of phospholipid-bound omega-3s compared to triglyceride/ethyl ester forms.

2. DHA-PC has been shown to cross the blood–brain barrier efficiently, elevating cerebral DHA and supporting cognitive function.

3. DPA uniquely promotes angiogenesis and endothelial repair, validated in animal and human studies.

4. Krill oil supplementation has demonstrated reductions in triglycerides, C-reactive protein, and improvements in HDL.

5. Phosphatidylcholine deficiency is linked to fatty liver disease, while supplementation restores hepatic function.

---

Conclusion & Implications

Phospholipid-bound omega-3s and DPA represent a paradigm shift in nutritional science, combining advanced bioavailability with multi-system functional targeting.

By integrating structural lipids, bioactive fatty acids, and antioxidant protection, they provide a precision nutrition approach for:

1. Cognitive decline and high cognitive workload

2. Cardiovascular and metabolic syndrome

3. Hepatic lipid disorders

4. Chronic inflammation and recovery

5. Reproductive and developmental health

This project, grounded in the Keyora Phospholipid–Omega Framework, emphasizes the potential of phospholipid-based omega-3 formulations as a next-generation nutritional strategy to promote systemic resilience, multi-organ protection, and healthy aging.